Jim Cramer spotlights Twilio, Apache, Tellurian, Atara Biotherapeutics, Amarin, Dynavax Technologies
Jim Cramer says this is a market that triumphs over the gloom by simply taking stock of the good and running with it. He's got your game plan for next week.
Amarin (AMRN) stock was declining after pricing its public offering at a discount.
A Tetraphase insider executed a well-timed insider stock sale right before the company's share price fell on negative clinical trial results.